As of 2025-05-30, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -33.22 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.38 USD, the upside of Forte Biosciences Inc is -496.39%.
Based on its market price of 8.38 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 496.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -33.22 - -33.22 | -33.22 | -496.39% |
| P/E | (163.84) - (211.66) | (193.30) | -2406.7% |
| DDM - Stable | (47.77) - (159.43) | (103.60) | -1336.3% |
| DDM - Multi | (27.79) - (78.11) | (41.69) | -597.5% |
| Market Cap (mil) | 40.60 |
| Beta | 2.27 |
| Outstanding shares (mil) | 4.85 |
| Enterprise Value (mil) | -5.25 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.16% |
| Cost of Debt | 5.00% |
| WACC | 8.41% |